Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3Neoplasms 2Plasmacytoma 1Pathologic Complete Response 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Large Granular Lymphocytic 1Hepatic Insufficiency 1Hematologic Neoplasms 1Hematologic Diseases 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

cc-486 1Raltegravir Potassium 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatic Insufficiency × cc-486 × 1 year × Clear all
NCT05209295 2026-01-12

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Bristol-Myers Squibb

Phase 1 Terminated
2 enrolled

Neoplasms, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡